Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites

Inclusion Criteria: * Subjects will have signed and dated an Institutional Review Board (IRB) approved informed consent form (ICF) prior to beginning any study-related activities * Subjects will be males and females between the ages of 18 to 70 years (inclusive) * Subjects must have a confirmed diagnosis of cirrhosis as determined by radiographical (presence of a nodular appearing liver on imaging), clinical (must have documentation from a provider and information verified independently by chart review), or histological evidence (presence of bridging fibrosis on a prior biopsy) * Subjects must have ascites based off of clinical or radiographical evidence * Subjects with a Model for End-Stage Liver Disease (MELD) score of less than 17 as documented by most recent lab results. Subjects must be capable of understanding the requirements of the study, be willing to comply with all the study procedures, and be willing to attend all study visits. * Females of childbearing (reproductive) potential must have a negative pregnancy test at screening and agree to use an acceptable method of contraception throughout their participation in the study. Acceptable methods of contraception include: * double barrier methods (condom with spermicidal jelly or a diaphragm with spermicide), * hormonal methods (e. g. oral contraceptives, patches or medroxyprogesterone acetate), or * an intrauterine device (IUD) with a documented failure rate of less than 1% per year. * Abstinence or partner…